Remove Pharma Remove Pharmaceutical Remove Pharmaceutical research
article thumbnail

PhRMA seeks to revive Medicare price negotiations lawsuit, blasts Biden's request for IRA expansion

Fierce Pharma

As President Joe Biden doubles down on the price negotiation meas | As President Joe Biden doubles down on the price negotiation measures in the Inflation Reduction Act, prominent industry lobbying group the Pharmaceutical Research and Manufacturers of America isn’t letting its legal challenge go down without a fight.

article thumbnail

And so pharma profiteers again

World of DTC Marketing

Bulgarian Prime Minister Bokyo Borissov this morning said the US pharmaceutical giant has increased the cost of future orders sold to the EU from €12 per dose to €19.50. This comes at a time when industry fart sniffing publications like Fierce Pharma report “pharma continues to shine under the pandemic spotlight.

Pharma 147
article thumbnail

PhRMA joins legal battle over Inflation Reduction Act's 'price-setting' measures

Fierce Pharma

After Merck and Bristol Myers Squibb took shots at the Inflation Reduction Act (IRA) in separate lawsuits, influential trade group Pharmaceutical Research and Manufacturers of America (PhRMA)—plus | Trade group PhRMA is the latest to go after the IRA in a lawsuit claiming violations of the Fifth and Eighth amendments.

article thumbnail

Appeals Court resurrects PhRMA's lawsuit challenging pricing provisions in IRA

Fierce Pharma

For trade group the Pharmaceutical Research and Manufacturers of America (PhRMA), the fight against pricing provisions in the Inflation Reduction Act isn’t over yet. Late last week, the U.S.

article thumbnail

After Pfizer's exit, UCB splits from industry trade group BIO

Fierce Pharma

UCB will still retain its membership in other top trade groups, including the Pharmaceutical Research and Manufacturers Association of America (PhRMA). . | Both companies opted not to renew their 2024 memberships with the Biotechnology Innovation Organization (BIO).

article thumbnail

Revolutionising Drug Discovery: AI Advances with Insilico Medicine's PandaOmics.

Pharma IQ

Discover how AI is transforming drug discovery and the future of AI in pharmaceutical research.

Medicine 130
article thumbnail

CPHI to return to Milan in 2024

European Pharmaceutical Review

CPHI, the global pharmaceutical event that spans the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging will return to Fiera Milano (Rho) in 2024. The Milan region is at the centre of Italy’s pharmaceutical base, with over 50 facilities in the Lombardy region alone.